Showing results (181-190 of 269) with videos related to

Sort By:
Pageof 27
The Journal of Infectious Diseases|March 4, 2014
Lipopolysaccharide, immune activation, and liver abnormalities in HIV/hepatitis B virus (HBV)-coinfected individuals receiving HBV-active combination antiretroviral therapyMegan Crane, Anchalee Avihingsanon, Reena Rajasuriar, et al.
The Journal of Antimicrobial Chemotherapy|February 13, 2026
Risk of hypertension in people with HIV in the USA initiating modern antiretroviral regimens: pooled analysis of blood pressure data from five clinical trialsPriscilla Y Hsue, Laura Waters, Chloe Orkin, et al.
The Journal of Antimicrobial Chemotherapy|February 21, 2008
Pharmacokinetics and short-term efficacy of a double-boosted protease inhibitor regimen in treatment-naive HIV-1-infected adultsJasper van der Lugt, Reshma Saskia Autar, Sasiwimol Ubolyam, et al.
Plos One|November 10, 2011
Factors associated with elevated ALT in an international HIV/HBV co-infected cohort on long-term HAARTJennifer Audsley, Eric C Seaberg, Joe Sasadeusz, et al.
AIDS Care|July 29, 2025
Factors associated with HIV-related stigma among adults living with HIV on antiretroviral therapy in the Asia-Pacific regionHay Mar Su Lwin, Win Min Han, Man Po Lee, et al.
The Lancet. HIV|July 14, 2023
Efficacy and safety of the novel capsid inhibitor lenacapavir to treat multidrug-resistant HIV: week 52 results of a phase 2/3 trialOnyema Ogbuagu, Sorana Segal-Maurer, Winai Ratanasuwan, et al.
Clinical Infectious Diseases : an Official Publication of the Infectious Diseases Society of America|July 24, 2024
Effects of Semaglutide on Muscle Structure and Function in the SLIM LIVER StudyGrace L Ditzenberger, Jordan E Lake, Douglas W Kitch, et al.
Tuberculosis (Edinburgh, Scotland)|May 1, 2012
A novel assay detecting recall response to Mycobacterium tuberculosis: Comparison with existing assaysDenise C Hsu, John J Zaunders, Marshall Plit, et al.
International Journal of Antimicrobial Agents|July 3, 2017
Impact of early versus deferred antiretroviral therapy on estimated glomerular filtration rate in HIV-positive individuals in the START trialAmit C Achhra, Amanda Mocroft, Michael Ross, et al.
Medicine|September 3, 2021
Prevalence and risk of residual viremia after ART in low- and middle-income countries: A cross-sectional studySivaporn Gatechompol, Lu Zheng, Yajing Bao, et al.
Pageof 27